Tag: beneficiaries

A novel approach to treating cancer is called chimeric antigen receptor (CAR) T-cell therapy. It’s a live medication derived from T cells, which are significant immune system white blood cells. The T cells are altered in a lab and then returned to your body to hunt for and eliminate cancer cells. Read More: CAR T…